These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20678234)

  • 1. The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats.
    Liu Q; Adams L; Broyde A; Fernandez R; Baron AD; Parkes DG
    Cardiovasc Diabetol; 2010 Aug; 9():32. PubMed ID: 20678234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.
    Liu Q; Anderson C; Broyde A; Polizzi C; Fernandez R; Baron A; Parkes DG
    Cardiovasc Diabetol; 2010 Nov; 9():76. PubMed ID: 21080957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats.
    Yu M; Moreno C; Hoagland KM; Dahly A; Ditter K; Mistry M; Roman RJ
    J Hypertens; 2003 Jun; 21(6):1125-35. PubMed ID: 12777949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of AC3174, a peptide analog of exendin-4.
    Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
    Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Syndrome Abolishes Glucagon-Like Peptide 1 Receptor Agonist Stimulation of SERCA in Coronary Smooth Muscle.
    Dineen SL; McKenney ML; Bell LN; Fullenkamp AM; Schultz KA; Alloosh M; Chalasani N; Sturek M
    Diabetes; 2015 Sep; 64(9):3321-7. PubMed ID: 25845661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
    Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
    Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of glucagon-like peptide-1, GLP-1
    Bremholm L; Andersen UB; Hornum M; Hilsted L; Veedfald S; Hartmann B; Holst JJ
    Physiol Rep; 2017 Feb; 5(4):. PubMed ID: 28235974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium alginate oligosaccharides attenuate hypertension and associated kidney damage in Dahl salt-sensitive rats fed a high-salt diet.
    Terakado S; Ueno M; Tamura Y; Toda N; Yoshinaga M; Otsuka K; Numabe A; Kawabata Y; Murota I; Sato N; Uehara Y
    Clin Exp Hypertens; 2012; 34(2):99-106. PubMed ID: 21967018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats.
    Grigorova YN; Juhasz O; Long JM; Zernetkina VI; Hall ML; Wei W; Morrell CH; Petrashevskaya N; Morrow A; LaNasa KH; Bagrov AY; Rapp PR; Lakatta EG; Fedorova OV
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GLP-1 analogue exenatide improves hepatic and muscle insulin sensitivity in diabetic rats: tracer studies in the basal state and during hyperinsulinemic-euglycemic clamp.
    Wu H; Sui C; Xu H; Xia F; Zhai H; Zhang H; Weng P; Han B; Du S; Lu Y
    J Diabetes Res; 2014; 2014():524517. PubMed ID: 25580440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.
    Patel V; Joharapurkar A; Dhanesha N; Kshirsagar S; Detroja J; Patel K; Gandhi T; Patel K; Bahekar R; Jain M
    Pharmacol Rep; 2013; 65(4):927-36. PubMed ID: 24145087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of hypertension with captopril affords better renal protection as compared with irbesartan in salt-loaded uremic rats.
    Weissgarten J; Berman S; Efrati S; Rapoport M; Modai D; Cohn M; Aladjem M; Galperin E; Averbukh Z
    Nephron Physiol; 2005; 101(1):p14-20. PubMed ID: 15925907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Cellular Repressor of E1A-Stimulated Genes Protects against Renal Fibrosis in Dahl Salt-Sensitive Rats.
    Liu ML; Song HX; Tian XX; Liu YX; Liu D; Hou ZW; Li JY; Yan CH; Han YL
    Am J Nephrol; 2020; 51(5):401-410. PubMed ID: 32320986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Blood Pressure Control: Role of Proximal Tubule Na
    Martins FL; Bailey MA; Girardi ACC
    Hypertension; 2020 Sep; 76(3):839-848. PubMed ID: 32755467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
    Wang B; Zhong J; Lin H; Zhao Z; Yan Z; He H; Ni Y; Liu D; Zhu Z
    Diabetes Obes Metab; 2013 Aug; 15(8):737-49. PubMed ID: 23433305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats.
    Li L; Guan Y; Kobori H; Morishita A; Kobara H; Masaki T; Nakano D; Nishiyama A
    Hypertens Res; 2019 Jun; 42(6):769-778. PubMed ID: 30587856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats.
    Vasdev S; Gill V; Parai S; Gadag V
    Mol Cell Biochem; 2005 Jul; 275(1-2):135-41. PubMed ID: 16335793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism.
    Wang D; Luo P; Wang Y; Li W; Wang C; Sun D; Zhang R; Su T; Ma X; Zeng C; Wang H; Ren J; Cao F
    Diabetes; 2013 May; 62(5):1697-708. PubMed ID: 23364453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß-cell function in non-diabetic, morbidly obese patients.
    Camastra S; Astiarraga B; Tura A; Frascerra S; Ciociaro D; Mari A; Gastaldelli A; Ferrannini E
    Diabetes Obes Metab; 2017 Mar; 19(3):412-420. PubMed ID: 27898183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats.
    Sufiun A; Rafiq K; Fujisawa Y; Rahman A; Mori H; Nakano D; Kobori H; Ohmori K; Masaki T; Kohno M; Nishiyama A
    Hypertens Res; 2015 Apr; 38(4):237-43. PubMed ID: 25588850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.